ARTES is pleased to announce the enlargement of the protective aera for their VLP development and production platform patent . The patent is about a “Method for Separating of Viruslike Particles from a Cell Suspension” and now valid in Europe and US.
https://artes-biotechnology.biz/wp-content/uploads/2021/09/5_ArtesVideo_Virus-VLP.png597597Melanie Piontekhttps://artes-biotechnology.biz/wp-content/uploads/2014/11/artes-Logo1-300x137.pngMelanie Piontek2021-09-07 10:56:022021-09-07 10:57:20VLP Purification Patent granted in US
Artes is pleased to announce the issuance of a new patent for their VLP development and production platform. The patent is about a “Method for Separating of Viruslike Particles from a Cell Suspension”.
https://artes-biotechnology.biz/wp-content/uploads/2020/03/MiMB_protocols_F1C_mod_inverted_ARTES_Blu.jpg13651353Melanie Piontekhttps://artes-biotechnology.biz/wp-content/uploads/2014/11/artes-Logo1-300x137.pngMelanie Piontek2021-04-29 11:43:102021-04-29 12:07:35VLP purification patent granted in EU
For more information: Novel Virus-Like Particle Vaccine Encoding the Circumsporozoite Protein of Plasmodium falciparum Is Immunogenic and Induces Functional Antibody Responses in Mice.
https://artes-biotechnology.biz/wp-content/uploads/2015/03/virus_20110614_01.jpg538564Melanie Piontekhttps://artes-biotechnology.biz/wp-content/uploads/2014/11/artes-Logo1-300x137.pngMelanie Piontek2021-04-09 14:28:132021-04-29 12:07:58ARTES and Burnet Institute publish data on new malaria vaccine candidates
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
VLP Purification Patent granted in US
ARTES is pleased to announce the enlargement of the protective aera for their VLP development and production platform patent . The patent is about a “Method for Separating of Viruslike Particles from a Cell Suspension” and now valid in Europe and US.
VLP purification patent granted in EU
Artes is pleased to announce the issuance of a new patent for their VLP development and production platform. The patent is about a “Method for Separating of Viruslike Particles from a Cell Suspension”.
ARTES and Burnet Institute publish data on new malaria vaccine candidates
For more information: Novel Virus-Like Particle Vaccine Encoding the Circumsporozoite Protein of Plasmodium falciparum Is Immunogenic and Induces Functional Antibody Responses in Mice.